ticker,published_utc,title,publisher,url
NBIX,2025-11-11T21:01:00+00:00,Neurocrine Biosciences to Present at Upcoming Investor Conferences,Yahoo,https://finnhub.io/api/news?id=e8ef8642c0392eb224b1bbb8a72bb5ea024cb7c43d5e8ba0fcb2a72a4d209161
NBIX,2025-11-11T17:45:03+00:00,Looking for a Growth Stock? 3 Reasons Why Neurocrine (NBIX) is a Solid Choice,Yahoo,https://finnhub.io/api/news?id=e034710594bf2684fb2769c184a27261c3a5ca9c50e8d8c6c77db5dc4af70e2d
NBIX,2025-11-10T21:05:00+00:00,Neurocrine Biosciences Provides Update on Phase 2 Study of NBI-1070770 in Adults with Major Depressive Disorder,Yahoo,https://finnhub.io/api/news?id=dfeca458e7cfac2f224a37168b888efbd3d599bf0fe713c156242ba60b39a364
NBIX,2025-11-10T18:25:00+00:00,Neurocrine chalks up a depression drug failure,Yahoo,https://finnhub.io/api/news?id=d8e0f8df5ed140beafc10eea39d6556105ce16dbeda857ea5000629ab8ba3d17
NBIX,2025-11-06T17:20:02+00:00,Earnings Estimates Rising for Neurocrine (NBIX): Will It Gain?,Yahoo,https://finnhub.io/api/news?id=3eaa3fb8e981f1aebebbb695554e097b6413e23340c640d4d126e9a37850da0e
NBIX,2025-11-06T11:37:54+00:00,3 Companies That May Be Priced Below Their Estimated Value,Yahoo,https://finnhub.io/api/news?id=6b6dcca6998c5129412e3f7a64e6a22ca826b8bfe4ac7eb453d6ae73fa74274d
NBIX,2025-11-05T20:18:21+00:00,How the Narrative Around Neurocrine Biosciences Is Evolving After Recent Results and Analyst Reactions,Yahoo,https://finnhub.io/api/news?id=2264cfb5813159a0dc47b26c49ca5dbbf95c047f87398423a6480b55d657efcc
NBIX,2025-11-04T17:00:04+00:00,What Makes Neurocrine (NBIX) a New Strong Buy Stock,Yahoo,https://finnhub.io/api/news?id=50a8ed9e8d219b48fe6a5488b1fcff0d8cc209b99c5b695ffeb8325a403a53d3
NBIX,2025-11-04T14:54:00+00:00,"Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus",Yahoo,https://finnhub.io/api/news?id=6d3e4e36ff248b700a836ec5f73ce0bcb4b9a6317bc08d60e678df2994cb2a44
NBIX,2025-10-30T20:15:21+00:00,Alnylam Stock Has Almost Doubled In 2025. But It Took A Hit On Earnings.,Yahoo,https://finnhub.io/api/news?id=07775eda7d73a9db0f82ab20c41121ffcab4224032b67682e7bb0bacfa17644f
NBIX,2025-10-30T19:21:27+00:00,Neurocrine Biosciences Inc (NBIX) Q3 2025 Earnings Call Highlights: Strong Sales Growth and ...,Yahoo,https://finnhub.io/api/news?id=b4cf00046188169a54933f4373da3dc6235a40dba73a0aa26e8f81d9b847270c
NBIX,2025-10-30T17:13:00+00:00,"Earnings roundup: Alnylam’s down day, Neurocrine’s head scratch and Biogen’s ‘low quality’ win",Yahoo,https://finnhub.io/api/news?id=0b7db40fdb24f96cfc1522576d238ff69d113c1cd783728c9e61141b9c70cde9
NBIX,2025-10-30T13:49:26+00:00,Alnylam Stock Has Already Doubled In 2025. But It Took A Hit On Earnings.,Yahoo,https://finnhub.io/api/news?id=78baf1033db2fd4034dfc08e0190f91c2e27375fc2d14a1e86a4616a00a7ec4f
NBIX,2025-10-30T10:24:07+00:00,Crinetics Pharmaceuticals: Its Post-FDA Approval Future,SeekingAlpha,https://finnhub.io/api/news?id=6415483aa2073f974f5d89f167e6a8792f0323778e05ebed916a646140ab62e1
NBIX,2025-10-30T10:14:53+00:00,Neurocrine Biosciences (NBIX): Net Margin Miss Challenges Bullish Earnings Growth Narratives,Yahoo,https://finnhub.io/api/news?id=06ef643e3530d513ca348bdf84416fd69c95589187600d5db61af5bbaf2f75ee
NBIX,2025-10-29T23:07:33+00:00,Neurocrine Biosciences (NBIX): Evaluating Valuation After Q3 Earnings Beat and Pipeline Progress,Yahoo,https://finnhub.io/api/news?id=6cc4a3f932000f857521cb5cba97b161e3a6ebd8382914bdc3ef051172703a45
NBIX,2025-10-29T16:54:58+00:00,Why Neurocrine Stock Was Spooked Despite Its Big Quarterly Beat,Yahoo,https://finnhub.io/api/news?id=afe8a03a6f0041e09045ab0f1626fb6a63ff8724c3087ee632c866480682dde7
NBIX,2025-10-29T01:03:08+00:00,Neurocrine Biosciences Beats Estimates But Wall Street Punishes The Stock,Yahoo,https://finnhub.io/api/news?id=305c6457e3083aa678e5d840a7791c0d04933eb7989cca6a1578d5b32a484605
NBIX,2025-10-28T23:30:02+00:00,Here's What Key Metrics Tell Us About Neurocrine (NBIX) Q3 Earnings,Yahoo,https://finnhub.io/api/news?id=bf480656bf6b9c735c20dece4112b1b5d2dfbd89b9030f3a6dadc401908445d6
NBIX,2025-10-28T21:31:50+00:00,"Neurocrine Biosciences, Inc. (NBIX) Q3 2025 Earnings Call Transcript",SeekingAlpha,https://finnhub.io/api/news?id=a24f89a53a84806281b69a4c97958f8eada466fc7e921afc3f260a8728459168
NBIX,2025-10-28T21:10:01+00:00,Neurocrine Biosciences (NBIX) Q3 Earnings and Revenues Top Estimates,Yahoo,https://finnhub.io/api/news?id=a699d57a64d7f10746d874879593bedf1dbd978383fe95ab08dde6c4176233d6
NBIX,2025-10-28T20:45:13+00:00,"Neurocrine Shares Rise, But Pull Back From Steep Gains, On Strong Ingrezza Quarter",Yahoo,https://finnhub.io/api/news?id=f3d97093e1bf401af903ec8d0b3a6cec9f9dff2f49e7a0cbf1de91b397c6a592
NBIX,2025-10-28T20:06:09+00:00,Neurocrine: Q3 Earnings Snapshot,Yahoo,https://finnhub.io/api/news?id=1dd3b353a450e5c618e5442c14b1a9419e26b1603e81a4fcaf392a9184ebae84
NBIX,2025-10-28T20:01:00+00:00,Neurocrine Biosciences Reports Third Quarter 2025 Financial Results,Yahoo,https://finnhub.io/api/news?id=5f583f458732f94ae048cf2501ccaef2636119df1ea46c7f8b22fa52463197c5
NBIX,2025-10-28T17:02:03+00:00,"Neurocrine Biosciences, Inc. 2025 Q3 - Results - Earnings Call Presentation",SeekingAlpha,https://finnhub.io/api/news?id=cd929829cf0b6e6996e076a4d035e1414e86012e96705bcdf3c273552290b5a0
NBIX,2025-10-25T12:14:32+00:00,Examining Neurocrine Biosciences Valuation After 24% Stock Surge and Pipeline Progress in 2025,Yahoo,https://finnhub.io/api/news?id=0ea5dd28804005581e765080863622e472ce33ddc228ad2150c3526b8aeb9d0a
NBIX,2025-10-24T16:00:02+00:00,Are You Looking for a Top Momentum Pick? Why Neurocrine Biosciences (NBIX) is a Great Choice,Yahoo,https://finnhub.io/api/news?id=73694a7f191fbee8909bfd6480b3ef3f02518d2dd7263b1ba71b8bcc26ecf32d
NBIX,2025-10-23T16:45:02+00:00,3 Reasons Why Growth Investors Shouldn't Overlook Neurocrine (NBIX),Yahoo,https://finnhub.io/api/news?id=8d119db5b163591d9f61d6f049968a50ab4d1b01d491057b6c2bfd5cd5abb90a
NBIX,2025-10-22T14:00:34+00:00,United Therapeutics (UTHR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release,Yahoo,https://finnhub.io/api/news?id=6946ab20bba94f3528402e7855d5415647e25e154603790fc1b45ee853881682
NBIX,2025-10-21T14:00:21+00:00,Neurocrine Biosciences (NBIX) Reports Next Week: Wall Street Expects Earnings Growth,Yahoo,https://finnhub.io/api/news?id=6547d057fdbd2fca8efdd4926d91bb2823efb0b0f1f3b22bdaba25d40b814089
NBIX,2025-10-20T11:38:07+00:00,Exploring High Growth Tech Stocks in the US This October 2025,Yahoo,https://finnhub.io/api/news?id=72c87f907699d9c61f08731374459edd380644c50c4dad2ef39d38c1cba87cef
NBIX,2025-10-18T04:47:54+00:00,Neurocrine Biosciences: Buy Rated As Q3 2025 Earnings Catalyst Approaches,SeekingAlpha,https://finnhub.io/api/news?id=403f0db4e7931bbcb15efd14cd95b40c4249e313ee2b4b8d55057a9e5f077858
NBIX,2025-10-17T12:30:00+00:00,Neurocrine Biosciences Presents New KINECT® 4 Post-Hoc Analysis Demonstrating Rapid and Sustained Therapeutic Efficacy of INGREZZA® (valbenazine) 40 mg Capsules,Yahoo,https://finnhub.io/api/news?id=7f5a2a88c53b0b845589d2db224a1ffaf89b3fd62cf22852f5c1c69fabfa4c4a
NBIX,2025-10-07T20:01:00+00:00,Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2025 Financial Results,Yahoo,https://finnhub.io/api/news?id=53baa3a57ce9e322f0fc898570b4349cdfef3d4d0c97452ca82ce99be9f796ac
NBIX,2025-10-07T14:26:22+00:00,A Fresh Look at Neurocrine Biosciences (NBIX) Valuation After Latest INGREZZA Clinical Study Results,Yahoo,https://finnhub.io/api/news?id=963330650facd4a3e47a11dd7227c5a472114ff6afa5a1d8c8c7578a82ac9767
NBIX,2025-10-06T20:05:00+00:00,"Neurocrine Biosciences Appoints Mike Sibley as Senior Vice President, General Manager of Neuropsychiatry Franchise",Yahoo,https://finnhub.io/api/news?id=8b96e13240c171e0a9630934a25b40b6c3042e45555543e23d836dfee18c63b5
NBIX,2025-10-06T19:52:16+00:00,Sector Update: Health Care Stocks Retreat Late Afternoon,Yahoo,https://finnhub.io/api/news?id=8ce48fdad5490789af4dffc3bcff8482599476d8b6295941cb85582791f9b5ce
NBIX,2025-10-06T12:30:00+00:00,Neurocrine Biosciences Presents New Three-Year Data Demonstrating Sustained Clinical Benefits and Established Safety Profile of INGREZZA® (valbenazine) Capsules for Huntington's Disease Chorea,Yahoo,https://finnhub.io/api/news?id=6f47eee71529c0edd6b1030696c82d4cc5476f85c6db37a3013b781edaea7253
NBIX,2025-09-25T13:55:53+00:00,Should You be Optimistic on Neurocrine Biosciences (NBIX)?,Yahoo,https://finnhub.io/api/news?id=057cf5737ed4ff92fcaad8de596c040c35632c6c17919c9d6083b0cd6377a0c9
NBIX,2025-09-24T15:40:04+00:00,GRFS or NBIX: Which Is the Better Value Stock Right Now?,Yahoo,https://finnhub.io/api/news?id=4efa672c6d91c32055eeae019410520dbcf61e3cd35a1ac71244410130b3939d
NBIX,2025-09-23T12:30:00+00:00,Neurocrine Biosciences Presents New Post-Hoc Analysis: Treatment with INGREZZA® (valbenazine) Capsules Achieves Earlier Remission of Tardive Dyskinesia Symptoms While Reducing Patient-Reported Disease Burden,Yahoo,https://finnhub.io/api/news?id=1200f4099d78f332d7a5b90512114d2a0687c7e71ce8f86a63bacdd550cbac9e
NBIX,2025-09-22T12:30:00+00:00,Neurocrine Biosciences Presents Positive New Data from Phase 2 Study of Osavampator in Adults with Major Depressive Disorder,Yahoo,https://finnhub.io/api/news?id=2ec5281dd3ad5798138933b056cfd4739a3580ef7615e3bfd0c43523704a7eae
NBIX,2025-09-19T18:38:14+00:00,Exploring High Growth Tech Stocks In The US Market September 2025,Yahoo,https://finnhub.io/api/news?id=24dc69a04abce03255842c322673854bb77a9073ddcb68fdec1f62b09a004e96
NBIX,2025-09-17T16:13:48+00:00,"Neurocrine Biosciences, Inc. (NBIX) Presents at TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit Transcript",SeekingAlpha,https://finnhub.io/api/news?id=c522349c208700e3e3d6f8216209a7e73c30d333848954140c3a9dd4660e1269
NBIX,2025-09-16T21:05:00+00:00,Neurocrine Biosciences to Present New Data from Phase 2 Study of Osavampator in Adults with Major Depressive Disorder at 38th Annual Psych Congress 2025,Yahoo,https://finnhub.io/api/news?id=7dbb544c55d287c8e1d1bbc0753c58cb4ca155470c7d47f331037f8f284c2a87
NBIX,2025-09-16T19:58:25+00:00,What Does Wall Street Think About Neurocrine Biosciences (NBIX)?,Yahoo,https://finnhub.io/api/news?id=63e35b829eba8022c759f61fe083bfdbbad9a94aff3ec287bc4a8c6a0f4fcc6b
NBIX,2025-09-09T13:37:38+00:00,"Neurocrine Biosciences, Inc. (NBIX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript",SeekingAlpha,https://finnhub.io/api/news?id=ca5b984d50d0dc3e2ba354b1cd12de4b4c758b49db04e8d88cebd5da03ba7109
NBIX,2025-09-03T15:20:46+00:00,"Neurocrine Biosciences, Inc. (NBIX) Presents At Cantor Global Healthcare Conference 2025 Transcript",SeekingAlpha,https://finnhub.io/api/news?id=eddba3df63055556e6d0c9d19431043bc4c7f457ab1e04476e20d3600938a1e1
NBIX,2025-09-02T09:03:54+00:00,"Neurocrine Biosciences, Inc. (NBIX) Beats Estimates on Neurology Drug Demand, Expands Payer Access",Yahoo,https://finnhub.io/api/news?id=1755212b1d9fe79fed6d8f985e3c8d1e1d39e07793e0cddd0a144e508563551f
NBIX,2025-08-28T07:00:00+00:00,Baird Small/Mid Cap Growth Equity Fund Q2 2025 Commentary,SeekingAlpha,https://finnhub.io/api/news?id=0f16b84f5cc08812c609f1fafb2ef3005543c837a906d710bb4d4ac65d6d522b
NBIX,2025-08-27T10:06:16+00:00,Stoke Therapeutics: Vulnerable To Profit Taking,SeekingAlpha,https://finnhub.io/api/news?id=dc8425df02fdbea38d9628383971dd9f47f3f0d8ddc7a0e7d22cd84a338a138a
NBIX,2025-08-26T20:01:00+00:00,Neurocrine Biosciences to Present at Upcoming Investor Conferences in September,Yahoo,https://finnhub.io/api/news?id=db34c48a73e33e7baf7f53e74ac6642ed0c84ec220df2cef78e3746c0c22731d
NBIX,2025-08-21T11:45:10+00:00,High Growth Tech Stocks To Watch In The US August 2025,Yahoo,https://finnhub.io/api/news?id=095f7d54565a7869f29e1bade2fe8df522a8a1109e911525439dfe9bdefd8ead
NBIX,2025-08-19T11:54:27+00:00,Inside XBI: What The SPDR S&P Biotech ETF Offers Investors,SeekingAlpha,https://finnhub.io/api/news?id=cc606c638667f35ffa0f8b62417f3e85c0aec2b5d0bda61e63fb0c4a426fb5a3
NBIX,2025-08-19T05:36:00+00:00,Macquarie Healthcare Fund Q2 2025 Commentary,SeekingAlpha,https://finnhub.io/api/news?id=655eb96db3e0f03d6d68a1ad112eac29691c479b1a0d5c889fa859d753088728
NBIX,2025-08-12T14:16:00+00:00,"Xenon Q2 Loss Wider Than Expected, Pipeline Development in Focus",Yahoo,https://finnhub.io/api/news?id=29a45fe2abf813e35f610b7891595e2ecb95dfa9b14e9a5d34fe8e5e3b421758
NBIX,2025-08-06T20:01:00+00:00,Neurocrine Biosciences to Present at the Canaccord Genuity 45th Annual Growth Conference,Yahoo,https://finnhub.io/api/news?id=316cde73c844aaa906d22ebefa9a0251ae3737e05bcbda7922fa8261435e73a5
NBIX,2025-08-01T10:24:18+00:00,Neurocrine Biosciences Second Quarter 2025 Earnings: Beats Expectations,Yahoo,https://finnhub.io/api/news?id=0165d0580024b9c9cf840c20a40c2b59c9318a9c2977ff88b7c8b484d533684d
NBIX,2025-07-31T08:24:19+00:00,Neurocrine Biosciences Positioned For Growth And New Potential Blockbusters,SeekingAlpha,https://finnhub.io/api/news?id=cf4375a578c3446fc9ac368e386ffc94ab3814d8f2ee159358b7dddec916b4fc
NBIX,2025-07-31T07:32:01+00:00,Neurocrine Biosciences Inc (NBIX) Q2 2025 Earnings Call Highlights: Strong Sales Growth and ...,Yahoo,https://finnhub.io/api/news?id=96e635df50b64d5695b0b9fdd1f48ea8b90ac8cb2e57d7af0b3acb309cac6c14
NBIX,2025-07-30T22:00:03+00:00,Here's What Key Metrics Tell Us About Neurocrine (NBIX) Q2 Earnings,Yahoo,https://finnhub.io/api/news?id=9fde56ff5a7c441be3cb9b95448cdf6dbeb8768241e8814dbfd9233e033810f2
NBIX,2025-07-30T21:10:01+00:00,Neurocrine Biosciences (NBIX) Q2 Earnings and Revenues Beat Estimates,Yahoo,https://finnhub.io/api/news?id=fe1e55c96d1cdc6adf8da4f7a309c681795e24d8ded71167fbbeda164282d310
NBIX,2025-07-30T20:18:39+00:00,"Neurocrine Biosciences, Inc. (NBIX) Q2 2025 Earnings Call Transcript",SeekingAlpha,https://finnhub.io/api/news?id=c5b5aa6eb11412d47de3bfc5d3b6d3157510b10c8231c10f293341a2f985cfb0
NBIX,2025-07-30T20:05:51+00:00,Neurocrine: Q2 Earnings Snapshot,Yahoo,https://finnhub.io/api/news?id=30cbaf923f96e68b406df590d478c06fc94c0c47f383657d9a7d0faf8fc6057f
NBIX,2025-07-30T20:01:00+00:00,Neurocrine Biosciences Reports Second Quarter 2025 Financial Results,Yahoo,https://finnhub.io/api/news?id=b1e7ecc6d412694d1f3f7cd06214a5418ad6753af8cd762f0c51e7c6c5909dc5
NBIX,2025-07-30T19:15:14+00:00,"Neurocrine Biosciences, Inc. 2025 Q2 - Results - Earnings Call Presentation",SeekingAlpha,https://finnhub.io/api/news?id=aa30c4fc8b241fd32e2a1829348d84b7bf452fa67634bc477b67905068d8336e
NBIX,2025-07-28T15:40:05+00:00,CPRX vs. NBIX: Which Stock Should Value Investors Buy Now?,Yahoo,https://finnhub.io/api/news?id=bff82f63c976c6f99f2cd6bde162cc27df9913f8215b93bec997710436eb0fd2
NBIX,2025-07-27T13:58:39+00:00,Neurocrine Biosciences Grows Pipeline While Maintaining Steady Investor Confidence,Yahoo,https://finnhub.io/api/news?id=4eec536dd4bc0d036576742226954ec9724dc90419c2471ff93dfcb07c8ced89
NBIX,2025-07-24T14:00:32+00:00,Indivior PLC (INDV) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release,Yahoo,https://finnhub.io/api/news?id=1d8e6f98ed62da39ad0cdf4956f37c4090eb70c3a62b510832e8addf8eee7ef9
NBIX,2025-07-23T17:38:24+00:00,High Growth Tech Stocks In US To Watch July 2025,Yahoo,https://finnhub.io/api/news?id=0d3e584e431f482a8ce245ef663e0bae7ee3bf6e9e8a8f4e5867489e48f749f2
NBIX,2025-07-23T14:00:31+00:00,Neurocrine Biosciences (NBIX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release,Yahoo,https://finnhub.io/api/news?id=255e22ebfe1322e80f77d08d05d266c44df166e5665594e5bef2978c41e9942d
NBIX,2025-07-15T14:57:26+00:00,Neurocrine shares new one-year data from trial of Crenessity for CAH,Yahoo,https://finnhub.io/api/news?id=6d14c7fa90a6b1bada98a3561d6be5b2a630be5c2e75883c59f669161934aa18
NBIX,2025-07-15T13:00:00+00:00,Neurocrine Biosciences Leverages PicnicHealth to Reveal Critical Care Gaps for Patients with Rare Genetic Condition,Yahoo,https://finnhub.io/api/news?id=8d574b7a422328db2061f3b14203fa860abc85cde75aa9b33bc0cc8a38bf7d4e
NBIX,2025-07-15T12:30:00+00:00,"Neurocrine Biosciences Presents New Analysis of CAHtalog® Registry Showing Most Patients with Classic Congenital Adrenal Hyperplasia Experienced High Glucocorticoid Exposure, Suboptimal Disease Control or Both at ENDO 2025",Yahoo,https://finnhub.io/api/news?id=b10b1db43d4d9a1451d1aea74d89f7fcedf9717cd4f420d61a692f0b919a7e0f
NBIX,2025-07-15T11:36:30+00:00,"Neurocrine Biosciences, Inc. Announces Results from New Analysis Using Real-World Data from CAHtalog",Finnhub,https://finnhub.io/api/news?id=de073e6016512043d363924af7e2b76d7ee9f04b841449b023eef3b7ab46632a
NBIX,2025-07-14T20:35:00+00:00,Neurocrine Biosciences Presented One-Year Data from Phase 3 CAHtalyst™ Studies Showing Improvements in Weight-Related Effects of Glucocorticoid Treatment at the 2025 Endocrine Society's Annual Meeting,Yahoo,https://finnhub.io/api/news?id=119eb8feec75494ae27f979169a7d962db8c12d86e2d55b930bd2f3ccf32f974
NBIX,2025-07-14T12:30:00+00:00,"Neurocrine Biosciences Presents One-Year Data Showing Sustained Efficacy of CRENESSITY® (crinecerfont) in Adult Patients, at ENDO 2025",Yahoo,https://finnhub.io/api/news?id=aa4b9485af0c706a08df6d234909f069126acfb08d3829787ce41cc012981ee6
NBIX,2025-07-14T09:50:41+00:00,"Neurocrine Biosciences, Inc. Presents One-Year Data Showing Sustained Efficacy of CRENESSITY in Adult Patients, at ENDO 2025",Finnhub,https://finnhub.io/api/news?id=8f6d1f7aa7d0b3b230ee484a4b6cb8e477e8bed6c171f62fab98e2c8131f3e76
NBIX,2025-07-11T03:26:44+00:00,"Untapped Patient Base, Ingrezza Growth Keep Neurocrine (NBIX) on Guggenheim’s Buy List",Yahoo,https://finnhub.io/api/news?id=0cb2ec8aa889a72f08b323288dc1b874905274f466d00ac81fda23c528f5342d
NBIX,2025-07-10T12:00:50+00:00,Acadia Emerges From Behind The Scenes With A Potential $12 Billion Opportunity,Yahoo,https://finnhub.io/api/news?id=63a18e1cc62212a9fc3de233bc2d0f85b2460b509cdad487fb5fbcd57e248b7f
NBIX,2025-07-09T20:01:00+00:00,Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2025 Financial Results,Yahoo,https://finnhub.io/api/news?id=cb508e037c24140ff606d42cb2c5b76acd64232976316b06b8ad5d77e61d0d9b
NBIX,2025-07-07T15:01:07+00:00,Neurocrine Biosciences : 2025 Corporate Responsibility Report,Finnhub,https://finnhub.io/api/news?id=dba5a59f71315faf7c3aca90a981b7eb0d5f65103716125f936f49385a52a9ae
NBIX,2025-07-04T12:40:21+00:00,Neurocrine Biosciences: Still A Buy After 30% Uplift Since My Last Coverage,SeekingAlpha,https://finnhub.io/api/news?id=034970e235b1fa124f9809ed40e584e7c7f8f73adbaf15d20e533088e8f438f9
NBIX,2025-07-03T14:40:00+00:00,NYLI Fiera SMID Growth Fund Q1 2025 Commentary,SeekingAlpha,https://finnhub.io/api/news?id=3c03cd0f06f0718c414d1203caa71674924fe036afea734df88029bd2d501d5c
NBIX,2025-07-01T23:20:00+00:00,Thrivent Mid Cap Stock Fund Q1 2025 Commentary,SeekingAlpha,https://finnhub.io/api/news?id=11928e53a22eeff676530f668cc4fa3675da7e4ac2839f558f7e26c016c24443
NBIX,2025-06-30T20:05:00+00:00,"Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBIP-01435, a Long-Acting Corticotropin-Releasing Factor Type 1 Receptor Antagonist",Yahoo,https://finnhub.io/api/news?id=e99e13bb5baae5a55251fd46110c70f990953d0a53ffc8163857a78caefca0a1
NBIX,2025-06-30T17:02:00+00:00,"Neurocrine Biosciences, Inc.(NasdaqGS: NBIX) added to Russell Midcap Value Index",Finnhub,https://finnhub.io/api/news?id=f8119fb511b688a3e4daa1522f25be04d01fb61d1a1af81c6a09f6464519875b
NBIX,2025-06-30T15:42:02+00:00,"Neurocrine Biosciences, Inc.(NasdaqGS: NBIX) added to Russell 3000 Value Index",Finnhub,https://finnhub.io/api/news?id=23827f8140bbeadc04ddd95c5ceb02cdbda447d2db0f12bfb0a33eb57b0e344a
NBIX,2025-06-30T14:06:53+00:00,"Neurocrine Biosciences, Inc.(NasdaqGS: NBIX) added to Russell 1000 Value-Defensive Index",Finnhub,https://finnhub.io/api/news?id=eaf3f69589e1010cf47090fd234c14a8f9de8b937305fc69120a16cdc682bfc4
NBIX,2025-06-30T12:08:28+00:00,"Neurocrine Biosciences, Inc.(NasdaqGS: NBIX) added to Russell 2500 Value Index",Finnhub,https://finnhub.io/api/news?id=dc086489497b8bbb594716cb9dcc0c4e648c965ebc9f0c47fb290100eaa6c5fd
NBIX,2025-06-30T08:58:17+00:00,"Neurocrine Biosciences, Inc.(NasdaqGS: NBIX) added to Russell 1000 Value Index",Finnhub,https://finnhub.io/api/news?id=09fc127316b533a0e2a959c9c2e9aece72c6fa695a3fed0c22d7dcf245a5d2a8
NBIX,2025-06-30T06:14:01+00:00,"Neurocrine Biosciences, Inc.(NasdaqGS: NBIX) added to Russell Small Cap Comp Value Index",Finnhub,https://finnhub.io/api/news?id=b26296e0aceef9273df7500db703d283515083d09ef1355b750e5a43ce3c12f1
NBIX,2025-06-29T22:44:06+00:00,"Neurocrine Biosciences, Inc.(NasdaqGS: NBIX) added to Russell 3000E Value Index",Finnhub,https://finnhub.io/api/news?id=569cc414a1f077a759f76ec7df3e4b9470e1abf6720e7978ea039ae43b21478a
NBIX,2025-06-27T15:20:33+00:00,"Neurocrine Biosciences, Inc. Presents New Post-Hoc Data Analyses from Kinect-Hd Study Demonstrating Significant Reduction in Disease Burden with Ingrezza®? (Valbenazine) Capsules for Huntington's Disease Chorea",Finnhub,https://finnhub.io/api/news?id=8e2b5ee1f04966d29ef526188a9bf72ba17eeb09aa871fa605481f22d9abd89d
NBIX,2025-06-27T12:30:00+00:00,Neurocrine Biosciences Presents New Post-Hoc Data Analyses from KINECT®-HD Study Demonstrating Significant Reduction in Disease Burden with INGREZZA® (valbenazine) Capsules for Huntington's Disease Chorea,Yahoo,https://finnhub.io/api/news?id=db455a8ada5b3235742ddd4643eaef3145f3ace8e095aa0a4645e712e210a859
NBIX,2025-06-23T15:40:03+00:00,CPRX vs. NBIX: Which Stock Is the Better Value Option?,Yahoo,https://finnhub.io/api/news?id=0da265565fce45c20847d01432ac77f24c4ec18b0df5fa4da0bdb3b42be0a92e
NBIX,2025-06-23T09:18:03+00:00,"Genmab: This Is Anything But A Value Trap, Yet It Is Currently Priced As One",SeekingAlpha,https://finnhub.io/api/news?id=4e760033ba4821df79b081935dac0af426335dcaf89076ab9b635b322cd8a901
NBIX,2025-06-20T17:38:05+00:00,Exploring 3 High Growth Tech Stocks In The US Market,Yahoo,https://finnhub.io/api/news?id=a2a1d19c4e6d0a1b9772b7349a7ad69dac073d9acbdc4faeab6263c8a084c114
NBIX,2025-06-20T12:30:00+00:00,Neurocrine Biosciences Presents New Data Showing Significant Patient-Reported Improvements in Health-Related Quality of Life with INGREZZA® (valbenazine) Capsules in Older Adults with Tardive Dyskinesia,Yahoo,https://finnhub.io/api/news?id=647a2efc77a59a22e1322084a615d3a6853965db0bb077084817ccad4ec1a079
NBIX,2025-06-20T10:05:35+00:00,"Neurocrine Biosciences, Inc. Presents New Data Showing Significant Patient-Reported Improvements in Health-Related Quality of Life with INGreZZA®? (valbenazine) Capsules in Older Adults with Tardive Dyskinesia",Finnhub,https://finnhub.io/api/news?id=d74b34ad6154cb4e3935adf2312781d1535b5f16db5ef4557938e63a3a669288
NBIX,2025-06-16T07:31:00+00:00,"S&P 500 Futures Up in Premarket Trading; Regencell Bioscience, EchoStar Lead",MarketWatch,https://finnhub.io/api/news?id=2ed46b12f7d8dcd5fb8c7d3277468ebff9bd95ac600c1476b4a0c2404786a83d
NBIX,2025-06-12T10:10:00+00:00,PGIM Jennison Health Sciences Fund Q1 2025 Commentary,SeekingAlpha,https://finnhub.io/api/news?id=61de796fc57a2eb31c888e46c0ee8624c4c0196c23f4d21c9936f0ecdc480f65
NBIX,2025-06-11T09:44:00+00:00,Harbor Long-Short Equity ETF Q1 2025 Commentary,SeekingAlpha,https://finnhub.io/api/news?id=4001480176008bbf4595c2c4c1a3084a811294b5079d7afe02aca435b6e56dce
NBIX,2025-06-09T20:05:00+00:00,Neurocrine Biosciences Appoints Lewis Choi as Chief Information Officer,Yahoo,https://finnhub.io/api/news?id=ea7983abe72609b08ca656463cccd3fbb7e71853e4b625f6ac8ccce0a6709a77
NBIX,2025-06-03T15:40:05+00:00,CPRX or NBIX: Which Is the Better Value Stock Right Now?,Yahoo,https://finnhub.io/api/news?id=b06ecf6009f6ad9aebf40a7cf7a077b6abe36d66a21d34ad72dd838fca90d9da
NBIX,2025-06-02T16:31:12+00:00,"Neurocrine Biosciences' Ingrezza to Meet Fiscal 2025 Sales Outlook, RBC Capital Says",Yahoo,https://finnhub.io/api/news?id=b7d6eee74b5babe6e32dcd74b7a7d7e085aa50d1e1d1f74bffb9c74c35835bf6
NBIX,2025-06-02T12:30:00+00:00,Neurocrine Biosciences Presents Patient-Reported Outcomes from KINECT-PRO™ Study Demonstrating INGREZZA® (valbenazine) Capsules Improved Functionality and Quality of Life in Patients with Tardive Dyskinesia,Yahoo,https://finnhub.io/api/news?id=d7d86dfaf3f7b7dfea44f9b6797a529f06b84c4b317e0ee7fd27656a72b18b9b
NBIX,2025-05-30T20:30:00+00:00,"Fate Therapeutics Appoints Matthew Abernethy, M.B.A., to its Board of Directors",Yahoo,https://finnhub.io/api/news?id=4fe484f320e9b4b0b31ae275f20c1b58c489ad0e69dbfdd47c134f5e779aee81
NBIX,2025-05-30T11:35:00+00:00,abrdn Healthcare Opportunities Fund Q1 2025 Commentary,SeekingAlpha,https://finnhub.io/api/news?id=b711ffff6bce49ff9d5022585a2f181130d7472e23b9296d94389bf9ea6cd4ef
NBIX,2025-05-29T04:03:27+00:00,"Neurocrine Biosciences, Inc. (NBIX)’s M4 Agonist Shows Promise in Schizophrenia Phase 2 Trial, Phase 3 Launched",Yahoo,https://finnhub.io/api/news?id=6d58399166cd00145e3f67f8fbfe0333704b5e36c05edc1400847358d54c7ce9
NBIX,2025-05-28T20:05:00+00:00,Neurocrine Biosciences Presents New Positive Data from Phase 2 Study of NBI-1117568 in Adults with Schizophrenia at American Society of Clinical Psychopharmacology 2025,Yahoo,https://finnhub.io/api/news?id=d92c5bcc2866ab9feb8cf325c01465d784e3798ee22b0466d646d562508f9127
NBIX,2025-05-23T12:52:03+00:00,Why Investors Should Watch Teva Despite Regional Risks,SeekingAlpha,https://finnhub.io/api/news?id=cf24b2a0bb360e2a3e02f53e94632fe654e0bd890ffdc8997680f5ed687da4e5
NBIX,2025-05-20T12:35:22+00:00,"Transcript : Neurocrine Biosciences, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2025, May-20-2025 11",Finnhub,https://finnhub.io/api/news?id=6c634fd2c26031cf4a62d27ca2659830c11376914b7c0ccd361bdc6494da24ee
NBIX,2025-05-19T09:23:06+00:00,Neurocrine Biosciences to Present Wide-Ranging One-Year Data from Phase 3 CAHtalyst Pediatric Study at Pediatric Endocrine Society 2025 Annual Meeting,Finnhub,https://finnhub.io/api/news?id=99dab39136f2f6c0413bc7ed7896d62701d14630b421146ee3c97b57e960c6f9
NBIX,2025-05-16T12:36:52+00:00,"Neurocrine Biosciences, Inc. Presents Data Adding to the Growing Body of Evidence Demonstrating Functional and Quality of Life Improvements in Patients with Tardive Dyskinesia",Finnhub,https://finnhub.io/api/news?id=165955c64e54e45114c214d066e2e868c7dd797c80ccf5b1432bf1ea7ce565e0
NBIX,2025-05-16T12:30:00+00:00,Neurocrine Biosciences to Present Wide-Ranging One-Year Data from Phase 3 CAHtalyst™ Pediatric Study at Pediatric Endocrine Society 2025 Annual Meeting,Yahoo,https://finnhub.io/api/news?id=a09271cde524cd7d59a77c8051d70aa91e7a59e656bb7724304fde734af5efeb
NBIX,2025-05-16T12:25:00+00:00,Neurocrine Biosciences Presents Data Adding to the Growing Body of Evidence Demonstrating Functional and Quality of Life Improvements in Patients with Tardive Dyskinesia,Yahoo,https://finnhub.io/api/news?id=e69cfe7fc23f595bf21c7abf4682a8cb6fcfc3f45d7cba3a00061702a564db93
NBIX,2025-05-16T09:50:22+00:00,Neurocrine Biosciences to Present Wide-Ranging One-Year Data from Phase 3 Cahtalyst?? Pediatric Study At Pediatric Endocrine Society 2025 Annual Meeting,Finnhub,https://finnhub.io/api/news?id=34245f2e2bc40ddebbeec9f2123fe0b28d0a6ab90101c45a2741259913b63b3a
NBIX,2025-05-15T20:05:00+00:00,Neurocrine Biosciences Presents Data on Improvements in Physiologic Glucocorticoid Dosing and Select Reproductive Hormones in Patients with Classic Congenital Adrenal Hyperplasia Taking CRENESSITY™ (crinecerfont),Yahoo,https://finnhub.io/api/news?id=1d0f2f4e1a39f3ad804195edd16960068e61d541e303038995180986eefacece
NBIX,2025-05-14T20:05:00+00:00,Neurocrine Biosciences Presents Findings Contributing to the Growing Body of Evidence on the Impact of High-Dose Glucocorticoids on Clinical Outcomes in Congenital Adrenal Hyperplasia,Yahoo,https://finnhub.io/api/news?id=843572c7a2f36181aede01f527060dd3857103ef5d5f1b599426fff536145976
NBIX,2025-05-13T19:48:53+00:00,"Neurocrine Biosciences, Inc. (NBIX): Among Billionaire Ken Griffin’s Midcap Stock Picks with Huge Upside Potential",Yahoo,https://finnhub.io/api/news?id=49f2e0fc7611ddf9cdc9e903d9808d8be861c9f76476424f9de932bf354f3496
NBIX,2025-05-12T10:49:42+00:00,Investors Can Find Comfort In Neurocrine Biosciences' (NASDAQ:NBIX) Earnings Quality,Yahoo,https://finnhub.io/api/news?id=f6c6b72b875253693fab1976e8e6a1387ab212dc3f975b2fe72f94c061df8dcf
NBIX,2025-05-08T18:59:09+00:00,"Neurocrine Biosciences, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now",Yahoo,https://finnhub.io/api/news?id=b81df7d5affae5ca40350eb06e24563f382b2351c59ed690f89fc06f9ce326cf
NBIX,2025-05-08T12:30:00+00:00,Neurocrine Biosciences Announces New Results from Exploratory Analyses of the Phase 3 CAHtalyst™ Pediatric Study Demonstrating CRENESSITY™ Reduces Glucocorticoid Dosing While Maintaining or Improving Androstenedione Across Patient Subgroups,Yahoo,https://finnhub.io/api/news?id=8d09160688dca1bec34f63a3dbf571d08ffe9c6c19d16ea7f34c24fe5aae0645
NBIX,2025-05-08T09:06:10+00:00,Neurocrine Reports Late Stage Data Of Crenessity,Finnhub,https://finnhub.io/api/news?id=b8cc0f0825185bd719b7dccb279766bcb9b777736ddf643e2fa4b524385a28b9
NBIX,2025-05-08T08:30:00+00:00,"Neurocrine Biosciences, Inc. Announces New Results from Exploratory Analyses of the Phase 3 CAHtalyst?? Pediatric Study",Finnhub,https://finnhub.io/api/news?id=18628fbbd70331df14abb6e50fd82f36b6503ae04df9341207a7c281d334bdd4
NBIX,2025-05-07T10:57:23+00:00,"Neurocrine Biosciences First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags",Yahoo,https://finnhub.io/api/news?id=72b74db370b80b549d3d1b996698d1ed6eb8aa2903b750dbbe77f44ca61d76be
NBIX,2025-05-07T07:34:42+00:00,"Why Neurocrine Biosciences, Inc. (NBIX) Skyrocketed On Tuesday",Yahoo,https://finnhub.io/api/news?id=b24ea4807248fe3ea9ae957777da6e19105f4851490c31710e665b910c921712
NBIX,2025-05-06T20:01:00+00:00,Neurocrine Biosciences to Present at Upcoming Investor Conferences in May,Yahoo,https://finnhub.io/api/news?id=b2805877c5a3f9022f0fb9769fa087362be9677acfdd027833315fc3ba457d8a
NBIX,2025-05-06T16:40:29+00:00,Neurocrine Biosciences Surges On 'Surprising' Momentum For Its Newest Drug,DowJones,https://finnhub.io/api/news?id=f792ae0dcc70cacb67ec0e1eb2aa88e4e45c113f48fd0752f9cb760107c8722c
NBIX,2025-05-06T12:36:00+00:00,Q1 2025 Neurocrine Biosciences Inc Earnings Call,Yahoo,https://finnhub.io/api/news?id=173842ac10c1f02b1565570f699c8ad8ef3c83e5642104620ae3bf96e492db11
NBIX,2025-05-06T12:30:00+00:00,Neurocrine Biosciences and Carnie Wilson Team Up to Launch ConnectING with Carnie™ Awareness Campaign for People with Tardive Dyskinesia,Yahoo,https://finnhub.io/api/news?id=3493278072867012d372c47bd507b9b09038a1d59a2cc0124886df441d3609f4
NBIX,2025-05-06T11:00:00+00:00,Neurocrine Biosciences Stock Rises on Revenue Beat as Ingrezza Sales Climb,MarketWatch,https://finnhub.io/api/news?id=69a38641c5999708ab59d7beaab5edafee883598b80ad2c7c319b4cecc3ab1ac
NBIX,2025-05-06T07:05:11+00:00,Neurocrine Biosciences Inc (NBIX) Q1 2025 Earnings Call Highlights: Strong INGREZZA Sales and ...,Yahoo,https://finnhub.io/api/news?id=02470831d07a02d9746104d6ef9325d0c9b38961f05a91e009858007fbd8f893
NBIX,2025-05-05T21:30:03+00:00,Neurocrine (NBIX) Reports Q1 Earnings: What Key Metrics Have to Say,Yahoo,https://finnhub.io/api/news?id=f856be5954c696a095647ee87eabffb9ea8086839622dad1bc27ea7d7e501e66
NBIX,2025-05-05T21:10:03+00:00,Neurocrine Biosciences (NBIX) Q1 Earnings Miss Estimates,Yahoo,https://finnhub.io/api/news?id=d6a9f4533f044a02b61fee28d2729a11b542a4d44626d7e22005035d01a12edd
NBIX,2025-05-05T20:33:05+00:00,"Neurocrine Biosciences, Inc. (NBIX) Q1 2025 Earnings Call Transcript",SeekingAlpha,https://finnhub.io/api/news?id=8ea8df69d8e00fe13374712496b54f07c4475c67a95c0efccdd6ca6802839088
NBIX,2025-05-05T20:09:28+00:00,Neurocrine: Q1 Earnings Snapshot,Yahoo,https://finnhub.io/api/news?id=d70162abe4a5feeb5805d1e1131df0df0a4ffe80af58be4acb9f32738d476ee4
NBIX,2025-05-05T20:01:00+00:00,Neurocrine Biosciences Reports First Quarter 2025 Financial Results and Reaffirms 2025 Financial Guidance,Yahoo,https://finnhub.io/api/news?id=66045c18602d104550ddc86d1d48517e8cff020a26e0a7ef4c21401724721f2d
NBIX,2025-05-05T16:01:00+00:00,"Transcript : Neurocrine Biosciences, Inc., Q1 2025 Earnings Call, May 05, 2025",Finnhub,https://finnhub.io/api/news?id=e165a92e1e31114f35563c38005b0158e5b356135c6e710ecceff84dfb44690d
NBIX,2025-05-05T12:30:00+00:00,Neurocrine Biosciences Announces New Survey Revealing Need for Routine Screening and Earlier Diagnosis for People Living with Tardive Dyskinesia,Yahoo,https://finnhub.io/api/news?id=2f093b461ba512fa0d6a1d1ff895746df27c62061a67e74bac78b6aa4c5584c0
NBIX,2025-05-01T11:18:10+00:00,Neurocrine begins Phase III programme for schizophrenia treatment,Yahoo,https://finnhub.io/api/news?id=8b46713437bbc738d779961e720d52b00471dd6ca036d2f3a566b170348c19f7
NBIX,2025-04-30T15:43:13+00:00,"Neurocrine Biosciences, Inc. (NBIX): Among Billionaire Cliff Asness’ Stock Picks with Huge Upside Potential",Yahoo,https://finnhub.io/api/news?id=020b5d0b238208dd4309bdacce0ea0a6bee6aa3d69c45989024bf0df06a5472d
NBIX,2025-04-30T15:06:59+00:00,Neurocrine Biosciences Starting Phase 3 Trial of Prospective Schizophrenia Medication,Yahoo,https://finnhub.io/api/news?id=2d602591557dfbda0cae0a353c1141e7a2245789f1f479cf050684e5a95713fd
NBIX,2025-04-30T12:00:00+00:00,Neurocrine Biosciences Initiates Phase 3 Registrational Program for NBI-1117568 as Potential Treatment for Adults with Schizophrenia,Yahoo,https://finnhub.io/api/news?id=653586a3057766891ca1efb36d72f235048bcf175a84c2e978ed9e45234f54ed
NBIX,2025-04-29T14:01:22+00:00,Zoetis (ZTS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release,Yahoo,https://finnhub.io/api/news?id=f8e9091ca74c287a4f8790e3f58ebc86cf5f251fb1d2cd1868c5342cf06082e0
NBIX,2025-04-28T14:00:35+00:00,Neurocrine Biosciences (NBIX) Q1 Earnings Preview: What's in the Cards?,Yahoo,https://finnhub.io/api/news?id=1d20e3c790dd7ee635df897f4df6996f181c4940966c71e2a77f056edd74e67e
NBIX,2025-04-25T10:12:34+00:00,Neurocrine Biosciences Publishes Analysis Showing Long-Term Efficacy and a Consistent Safety Profile of INGREZZA Capsules in Older Adults with Tardive Dyskinesia in the Journal of Clinical Psychiatry,Finnhub,https://finnhub.io/api/news?id=ba226ddbc2dacd2e527e1dfa9c1402face84092d9b3d5191f42b89248d405c6a
NBIX,2025-04-24T20:05:00+00:00,Neurocrine Biosciences Publishes Analysis Showing Long-Term Efficacy and a Consistent Safety Profile of INGREZZA® (valbenazine) Capsules in Older Adults with Tardive Dyskinesia in The Journal of Clinical Psychiatry,Yahoo,https://finnhub.io/api/news?id=92bb970a90219cdf331ba1eaac68d9763da43f42bbc4a6b87ae36ec1db3561f9
NBIX,2025-04-22T18:05:10+00:00,Neurocrine Biosciences: Valbenazine As Adjunctive Therapy Could Stage Comeback In 2025,SeekingAlpha,https://finnhub.io/api/news?id=7e347350066bf0041b6f9b9af398bb92318a4d3596d3fe0684d2bbc7e4d2d1fa
NBIX,2025-04-22T10:37:44+00:00,"With EPS Growth And More, Neurocrine Biosciences (NASDAQ:NBIX) Makes An Interesting Case",Yahoo,https://finnhub.io/api/news?id=57740a9b22b85d017061e40df4aabfbbce86fb8ac8a9072e89272f8ca84377c8
NBIX,2025-04-16T17:51:33+00:00,Neurocrine Biosciences: Recent Selloff Has Created A Potential Buying Opportunity,SeekingAlpha,https://finnhub.io/api/news?id=7a543421532715472fe76ab340824534055f07bbab4dc5aca600ad311e8b8262
NBIX,2025-04-14T20:01:00+00:00,Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2025 Financial Results,Yahoo,https://finnhub.io/api/news?id=69f32ae20147a14b2bbcf20a72761a6ff58a347f307afef1c28f26b5670f340e
NBIX,2025-04-09T16:39:20+00:00,Neurocrine Biosciences : 2024 Annual Report*,Finnhub,https://finnhub.io/api/news?id=789d58b580f1f7b4f9c2f7f347a334be293870402e91cee09b60866b18bca387
NBIX,2025-04-07T15:39:00+00:00,Implied Volatility Surging for Neurocrine Biosciences (NBIX) Stock Options,Yahoo,https://finnhub.io/api/news?id=86bba75498affc8817f7420ed2b7ab140ba6fc880d9d2476d34299677a08203a
NBIX,2025-04-07T07:04:15+00:00,Neurocrine Biosciences Appoints Dr. Sanjay Keswani as Chief Medical Officer,Finnhub,https://finnhub.io/api/news?id=a0ad8e9b8075b04ebb4ec05119750458ff3967dbc5e49e38175e21afbb630a7b
NBIX,2025-03-31T16:03:00+00:00,Impax Small Cap Fund Q4 2024 Commentary,SeekingAlpha,https://finnhub.io/api/news?id=9084ffe7f43bf8356e2621b40d5548994ef04b1dba6a48c298d1b14a3911a16c
NBIX,2025-03-31T12:30:00+00:00,Neurocrine Biosciences Presents Real-World Data on Therapeutic Dose Attainment and Dosing Trends of VMAT2 Inhibitors in Patients With Tardive Dyskinesia,Yahoo,https://finnhub.io/api/news?id=ed65c8a2c0b8bce763f6e1638bbeb5ac2c618ef7287b10a06bb92f2e41b90de6
NBIX,2025-03-28T15:59:00+00:00,Baird Q4 2024 Small/Mid Cap Growth Equity Commentary,SeekingAlpha,https://finnhub.io/api/news?id=8cc4cda307a10583cfd85f6d3163af930fe0897d2474def3aa40d766174ddb46
NBIX,2025-03-27T07:30:00+00:00,Franklin Biotechnology Discovery Fund Q4 2024 Commentary,SeekingAlpha,https://finnhub.io/api/news?id=743b5137aca60badcb2ace1e5601b3a1d46e916bce67c484c60523c28bfb157b
NBIX,2025-03-25T11:08:28+00:00,Exploring High Growth Tech Stocks in US for March 2025,Yahoo,https://finnhub.io/api/news?id=eed166e50071a54b865b7f486ed557c791451b7b2512bb37b1d905a79ad7158e
NBIX,2025-03-20T17:45:02+00:00,Neurocrine Biosciences debuts new data for effectiveness of Ingrezza,Yahoo,https://finnhub.io/api/news?id=c4255085af961d42baa9cec9b6ee293cf264d8b284fc400000668d89837fa652
NBIX,2025-03-20T12:30:00+00:00,Neurocrine Biosciences Presents 48-Week Remission Data on Treatment of Tardive Dyskinesia With INGREZZA® (valbenazine) Capsules,Yahoo,https://finnhub.io/api/news?id=94d7101f375197545ac261af02e52360ad2d3913a2b44f41cabf774e7b02d018
NBIX,2025-03-20T09:05:00+00:00,Invesco Health Care Fund Q4 2024 Commentary,SeekingAlpha,https://finnhub.io/api/news?id=8f81827abb6ec00be306ef52a83e31acbe2c243bf3d6f7d992305822a81d2a8e
NBIX,2025-03-18T09:15:45+00:00,Neurocrine Biosciences (NBIX): Among the Best Biotech Stocks to Buy According to Billionaires,Yahoo,https://finnhub.io/api/news?id=12c01c30b0b37a7619afae7f81e3c6fb4eea224432b1667f1b9f4e7df7a32073
NBIX,2025-03-17T12:30:00+00:00,Neurocrine Biosciences Presents New KINECT®-HD Data Showing Significant Reduction in Chorea Across Body Regions With INGREZZA® (valbenazine) Capsules,Yahoo,https://finnhub.io/api/news?id=a6b5e5d3fad60d82d4a195bc262612e29e810c8978e985c93b328bcd6a4a142f
NBIX,2025-03-14T09:30:00+00:00,Big Pharma Walked Away From Mental Health. Why Some Are Coming Back.,Yahoo,https://finnhub.io/api/news?id=647713b5d7a0f754f1eb422329ff7d6f6b53fbeb68dfd1d173d7250004069c1b
NBIX,2025-03-11T20:01:00+00:00,Neurocrine Biosciences to Present at the Stifel 2025 Virtual CNS Forum,Yahoo,https://finnhub.io/api/news?id=87192f787ef2cbb5081572bc89995d50c260df94beba427f373690df1f0017e3
NBIX,2025-03-06T17:20:01+00:00,Neurocrine Biosciences (NasdaqGS:NBIX) Begins Phase 1 Study Of New VMAT2 Inhibitor For Neurological Conditions,Yahoo,https://finnhub.io/api/news?id=c5f48d2b559de04858ba34476ae83e0f66a68e6ee14705431cd3dabeb44f5595
NBIX,2025-03-06T12:26:52+00:00,Neurocrine Biosciences initiates trial of VMAT2 inhibitor in healthy adults,Yahoo,https://finnhub.io/api/news?id=e4a786cb92823e0f9db89571a0e17ab64557e2458ce59421c6ac4e4d4efda819
NBIX,2025-03-05T13:30:00+00:00,"Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBI-1140675, a Second-Generation VMAT2 Inhibitor, in Healthy Adults",Yahoo,https://finnhub.io/api/news?id=35a9ee79bd674f44a7d151c6b8b42d86f7c7b7c400e358b448f8540bec48feec
NBIX,2025-02-27T21:05:00+00:00,Neurocrine Biosciences Reports Patient-Reported Outcome Data from KINECT-PRO™ Study for INGREZZA® (valbenazine) Capsules in Tardive Dyskinesia: Significant and Clinically Meaningful Improvements in Functionality and Quality of Life Measures,Yahoo,https://finnhub.io/api/news?id=ece6f619c257ab5c327739688a3a6c9dda4e8a8ba19e369f1f9a10cf4cb832aa
NBIX,2025-02-25T21:01:00+00:00,Neurocrine Biosciences to Present at Upcoming Investor Conferences in March,Yahoo,https://finnhub.io/api/news?id=70f83f8a52b1df0a5702c9075605f0b5827e454ca52ba3033a4e5e1feec62a8f
NBIX,2025-02-24T14:02:15+00:00,High Growth Tech Stocks To Watch In February 2025,Yahoo,https://finnhub.io/api/news?id=96feee71d8d7d3e5a8a7f42cb527383d9f5a5e6c64d533673b1ea2a89b7dcd26
NBIX,2025-02-24T11:10:46+00:00,Neurocrine Biosciences Board of Directors Authorizes $500 Million Share Repurchase Program,Finnhub,https://finnhub.io/api/news?id=dfa46f0e10b5a4f58275fc9cb1aa3f75ef63507a70204e41a7ca8af936d7237f
NBIX,2025-02-21T20:11:46+00:00,Is Neurocrine Biosciences (NBIX) One of the Best Fast Growth Stock to Buy Right Now?,Yahoo,https://finnhub.io/api/news?id=07381502eddc206de5f99117be1fde74699aa55ba2127a2f701811a6cb02b01e
NBIX,2025-02-21T18:26:41+00:00,Neurocrine Biosciences' (NASDAQ:NBIX) Performance Is Even Better Than Its Earnings Suggest,Yahoo,https://finnhub.io/api/news?id=fef2be1b00452da1997bdbea053c1fcb870bfa45fce033e502013147f33d5c3e
NBIX,2025-02-18T21:08:27+00:00,Neurocrine (NBIX): Among Top Insider Stock Buys And Sells In January,Yahoo,https://finnhub.io/api/news?id=367eb84a1c81bb1c8ce5605daf9aa5d5a1c9969f8d3c6f81a27c67ec64827d07
NBIX,2025-02-10T23:18:59+00:00,Why Neurocrine Biosciences Stock Sank Today,Yahoo,https://finnhub.io/api/news?id=8447520d24d47c61b4c66fc2a4b8ddc74b9e7f17227ae85b2305e02484b01424
NBIX,2025-02-10T13:32:18+00:00,Why Neurocrine Biosciences Inc. (NBIX) Crashed Last Week,Yahoo,https://finnhub.io/api/news?id=144c97bda2a0f22b7b0cf8bd9f747b26ce142005a7d71954e5a91dc3e6e47d55
NBIX,2025-02-08T16:01:13+00:00,Here’s Why Neurocrine Biosciences Inc. (NBIX) Crashed on Friday,Yahoo,https://finnhub.io/api/news?id=cce4a7bbf6ad98f829310861e3c294285b837d2d877c2b007964c84911440424
NBIX,2025-02-08T12:27:23+00:00,Neurocrine Biosciences' (NASDAQ:NBIX) underlying earnings growth outpaced the notable return generated for shareholders over the past three years,Yahoo,https://finnhub.io/api/news?id=62011a5ff6baad95dd8544e676bd2cd80d7b077dbdb99ed5c3c5d83a33b9114e
NBIX,2025-02-07T21:43:32+00:00,Neurocrine Crumbles On Lackluster Guidance For Its Bread-And-Butter Drug,Yahoo,https://finnhub.io/api/news?id=0d8859c34073a54fcc179644f1ad167ca11b7cd21835ad3832bda99807675de0
NBIX,2025-02-07T21:25:00+00:00,"These Stocks Moved the Most Today: Amazon, Tesla, Uber, Affirm, Pinterest, Take-Two, Expedia, Bill, e.l.f. Beauty, and More",Yahoo,https://finnhub.io/api/news?id=7f81d089d4d7bdfec8b29bf5d939e4675f6a4452f290ae0ea58e40a26b0aef79
NBIX,2025-02-07T18:05:56+00:00,Why Is Neurocrine Biosciences Stock Trading Lower On Friday?,Yahoo,https://finnhub.io/api/news?id=054b47e95c7636bc07e6bbd93618067f295e5ad7fe96b3e1e999b93beb593bb4
NBIX,2025-02-07T13:15:43+00:00,Q4 2024 Neurocrine Biosciences Inc Earnings Call,Yahoo,https://finnhub.io/api/news?id=1e44ab1a7e62ade0cb15faeffbd34883270517978a59a5daa5f1b6d3c3d423c7
NBIX,2025-02-06T22:52:04+00:00,"Neurocrine Biosciences, Inc. (NBIX) Q4 2024 Earnings Call Transcript",SeekingAlpha,https://finnhub.io/api/news?id=74fb4b017b9a7af8daedd6dd1d89de6566b1a38746f63d584ae567dc00598941
NBIX,2025-02-04T07:52:30+00:00,Neurocrine Biosciences Q4 Earnings Preview: What To Expect After The New Drug Approval,SeekingAlpha,https://finnhub.io/api/news?id=5a17c90809aab0caba6a6e6a9168cc41ee1d731d0b3beb558eb75d5c7943f192
NBIX,2025-02-02T06:09:56+00:00,Wall Street Week Ahead,SeekingAlpha,https://finnhub.io/api/news?id=b628db79bec8b4ba19db49d42ef374af40f7c9effdf8a9adc7a8aa86c521dc6d
NBIX,2025-02-01T11:00:00+00:00,"Busy Earnings Season Continues With Alphabet, Disney, Palantir To Report Results",SeekingAlpha,https://finnhub.io/api/news?id=4183cd54aed2c97e8c317416c61a1ac1dab36e61d22ba5d773abed5f29b17495
NBIX,2025-01-28T08:31:10+00:00,Neurocrine Biosciences Announces Initiation of Phase 3 Registrational Program for Osavampator as an Adjunctive Therapy for the Treatment of Major Depressive Disorder in Adults,Finnhub,https://finnhub.io/api/news?id=5c5b8b0636608b2e523be38ba70821e032872902cd55fa9196187e2e52655ec1
NBIX,2025-01-27T19:04:14+00:00,"Stocks to Watch : Graco, Brown & Brown, Neurocrine Biosciences",Finnhub,https://finnhub.io/api/news?id=c145bb34e518f7252b7950fa38122402a55de9964859bdc0289173264c93d7a2
NBIX,2025-01-27T18:48:00+00:00,"Stocks to Watch: Graco, Brown & Brown, Neurocrine Biosciences",MarketWatch,https://finnhub.io/api/news?id=b828ef76944dc1161f29580718551b0174782bfca60399b425c01d422276c213
NBIX,2025-01-27T17:37:10+00:00,Neurocrine Amends Agreement With Takeda for Major Depressive Disorder Treatment,Finnhub,https://finnhub.io/api/news?id=87960ee626759e222171a3840b51a8c37b8e1e70250fd999480278e533723362
NBIX,2025-01-27T16:06:08+00:00,Neurocrine Biosciences Announces Amendment to Strategic Collaboration with Takeda to Develop and Commercialize Osavampator (formerly NBI-1065845/TAK-653),Finnhub,https://finnhub.io/api/news?id=68a52ffc4b58ff6a5dc0135e8aaabd95c4faad65e90055a0cddb7dd1053bee41
NBIX,2025-01-23T16:06:16+00:00,"Andrew Ratz, Ph.D., Joins Neurocrine Biosciences as Senior Vice President of Drug Development, Delivery and Device",Finnhub,https://finnhub.io/api/news?id=9a7bbe85299d304e29d16b802f7e124f361ea85840d8f80f086fbb612620eab8
NBIX,2025-01-21T18:27:23+00:00,Solid Biosciences: Differentiating Factors Of SGT-212 To Set Itself Apart,SeekingAlpha,https://finnhub.io/api/news?id=4b9c04102b24516f8bb42661f5382ca35d88adf447e53f4cd7ae881a64af3ab2
NBIX,2025-01-21T16:06:10+00:00,Neurocrine Biosciences Announces Classic Congenital Adrenal Hyperplasia Supplement Published Today in The Journal of Clinical Endocrinology & Metabolism,Finnhub,https://finnhub.io/api/news?id=7a05621959a357c7af4d2430c9cc76e1d0dc8421cfdd720875004871b276ea6a
NBIX,2025-01-09T14:06:35+00:00,Exploring High Growth Tech Stocks in January 2025,Yahoo,https://finnhub.io/api/news?id=0a70446f320eaf993a385eb7da831c918e3b20b6dd28d9569287518c5c51cbee
NBIX,2025-01-08T13:30:00+00:00,Neurocrine Biosciences Announces Publication on Traditional Glucocorticoid Treatment in Classic Congenital Adrenal Hyperplasia in Expert Review of Endocrinology & Metabolism,Yahoo,https://finnhub.io/api/news?id=4858eb21f4ac0991032a66a1fb55fece1e03e6e1a22a46b0e23ba47f64211674
NBIX,2025-01-06T21:01:00+00:00,Neurocrine Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference,Yahoo,https://finnhub.io/api/news?id=b38ab471f6a9c15d7682211e1fb8eba9474bbf3433add28fc4d136fef15ab0f6
NBIX,2024-12-24T20:23:00+00:00,Neurocrine Biosciences Stock Sees RS Rating Upgrade,Yahoo,https://finnhub.io/api/news?id=25f03a381d6be30522a8d319ebdf5cc4921dfe729e84f29341a996c598298d4b
NBIX,2024-12-24T09:50:44+00:00,"Neurocrine Biosciences, Inc. Selects PANTHERxRare Specialty Pharmacy for Distribution of Crenessity (crinecerfont)",Finnhub,https://finnhub.io/api/news?id=8aad1673980d80720a30356ff8e2cc2bccc43f4c29409c0f632f8fb32dacb7f9
NBIX,2024-12-23T14:43:00+00:00,Enanta Pharmaceuticals (ENTA) Moves 7.2% Higher: Will This Strength Last?,Yahoo,https://finnhub.io/api/news?id=713dffb95368cbdca83b9f19bf900de0e1aceb71bcbc5d6e4438db4fbbe3acac
NBIX,2024-12-23T11:24:17+00:00,Neurocrine Biosciences Announces Commercial Availability of CRENESSITY for Children and Adults with Classic Congenital Adrenal Hyperplasia,Finnhub,https://finnhub.io/api/news?id=8b6372451115728402b5d723f8bbdae6de7e01abb598b94dbf2ac8d7bcfab5b1
NBIX,2024-12-20T13:00:00+00:00,Neurocrine Biosciences Announces Commercial Availability of CRENESSITY™ (crinecerfont) for Children and Adults With Classic Congenital Adrenal Hyperplasia,Yahoo,https://finnhub.io/api/news?id=389311657af124dabe6c1ed617bd37fc35201650d104c754b75210af22fb3a60
NBIX,2024-12-20T08:10:04+00:00,Neurocrine Biosciences : Announces Commercial Availability of CRENESSITY™ (crinecerfont) for Children and Adults With Classic Congenital Adrenal Hyperplasia Form 8 K,Finnhub,https://finnhub.io/api/news?id=23253540cbd54e12dff34de6fa9f36d04c1d343fd3f170ca72418372db61fdd6
